Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36926 - 36950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	DAZL	1618	downregulated	entinostat results in decreased expression of DAZL mRNA	3p24.3	A21037
Entinostat	Investigational	DCAF4	26094	upregulated	entinostat results in increased expression of DCAF4 mRNA	14q24.2	A21037
Entinostat	Investigational	DCC	1630	upregulated	entinostat results in increased expression of DCC mRNA	18q21.2	A21037
Entinostat	Investigational	DCDC5	100506627	upregulated	entinostat results in increased expression of DCDC5 mRNA	11p14.1	A21035
Entinostat	Investigational	DCLK1	9201	downregulated	entinostat results in decreased expression of DCLK1 mRNA	13q13.3	A21035
Entinostat	Investigational	DCLK1	9201	upregulated	entinostat results in increased expression of DCLK1 mRNA	13q13.3	A21037
Entinostat	Investigational	DCLK2	166614	downregulated	entinostat results in decreased expression of DCLK2 mRNA	4q31.23-q31.3	A21037
Entinostat	Investigational	DCN	1634	upregulated	entinostat results in increased expression of DCN mRNA	12q21.33	A21035
Entinostat	Investigational	DCXR	51181	upregulated	entinostat results in increased expression of DCXR mRNA	17q25.3	A21037
Entinostat	Investigational	DDAH2	23564	downregulated	entinostat results in decreased expression of DDAH2 mRNA	6p21.33	A21037 A21035
Entinostat	Investigational	DDC	1644	downregulated	entinostat results in decreased expression of DDC mRNA	7p12.2-p12.1	A21035
Entinostat	Investigational	DDIT4L	115265	downregulated	entinostat results in decreased expression of DDIT4L mRNA	4q24	A21037
Entinostat	Investigational	DDX17	10521	downregulated	entinostat results in decreased expression of DDX17 mRNA	22q13.1	A21035
Entinostat	Investigational	DDX60L	91351	upregulated	entinostat results in increased expression of DDX60L mRNA	4q32.3	A21035
Entinostat	Investigational	DEF6	50619	upregulated	entinostat results in increased expression of DEF6 mRNA	6p21.31	A21037
Entinostat	Investigational	DEFA5	1670	downregulated	entinostat results in decreased expression of DEFA5 mRNA	8p23.1	A21035
Entinostat	Investigational	DEFB1	1672	downregulated	entinostat results in decreased expression of DEFB1 mRNA	8p23.1	A21035
Entinostat	Investigational	DEGS1	8560	upregulated	entinostat results in increased expression of DEGS1 mRNA	1q42.11	A21037 A21035
Entinostat	Investigational	DENND1A	57706	downregulated	entinostat results in decreased expression of DENND1A mRNA	9q33.3	A21037
Entinostat	Investigational	DENND1B	163486	downregulated	entinostat results in decreased expression of DENND1B mRNA	1q31.3	A21037
Entinostat	Investigational	DENND1C	79958	upregulated	entinostat results in increased expression of DENND1C mRNA	19p13.3	A21035
Entinostat	Investigational	DENND2A	27147	downregulated	entinostat results in decreased expression of DENND2A mRNA	7q34	A21037
Entinostat	Investigational	DENND2C	163259	upregulated	entinostat results in increased expression of DENND2C mRNA	1p13.2	A21037
Entinostat	Investigational	DEPDC7	91614	upregulated	entinostat results in increased expression of DEPDC7 mRNA	11p13	A21037
Entinostat	Investigational	DEPTOR	64798	upregulated	entinostat results in increased expression of DEPTOR mRNA	8q24.12	A21037

Displaying entries 36926 - 36950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability